Cafe X

Café X will bring together faculty, staff, students and the broader community, to cultivate and develop “blue sky” thinking about topical issues and leading edge ideas. Invited speakers will share experiences in exciting innovative areas that will spark discussion, provoke debate and elicit thoughtful ideas.



Featuring ...

Danielle Zyngier

Dr. J. Paul Santerre (PhD '90 Chemical Engineering)
Professor, Faculty of Dentistry and Institute of Biomaterials & Biomedical Engineering, University of Toronto

"A Perspective on University Derived Innovation and Entrepreneurship"

Monday, March 9, 2015
3:30 pm - 5:00 pm

McMaster University, ETB room 535



In the US, the health care industry consumes about 14-16% of the gross domestic product (similar to its relative scale in Canada at 10-12%). It is projected as one of the world’s largest and fastest-growing industries, reaching 20% of the US Gross Domestic Product by 2016. Engineering principles are applied in hospitals, nursing homes, diagnostic laboratories, pharmacies, medical device manufacturing, rehabilitation services and many other areas, yielding significant potential for biomedical engineers. Canadian academic institutions can no longer delay the introduction of creative curriculum to address this commercial potential for our graduating youth. Our faculty should do everything in their collective power to contribute to applying innovative knowledge within an entrepreneurial setting and partnering with critical stakeholders.

About Paul Santerre:

Paul Santerre is a trailblazer in biomaterials and biomedical engineering,” said Cristina Amon, dean of the Faculty of Applied Science & Engineering of University of Toronto. “Not only is he pioneering innovative research, but he is also transferring his findings directly to market so they can improve health care for people around the world.”

Professor J. Paul Santerre has published over 150 peer reviewed publications and is a listed inventor on over 55 patents in the area of polymers, biodegradation, surface modification and drug delivery. He was the past Associate Dean Research in the Faculty of Dentistry, and subsequently Director for the Institute of Biomaterials and Biomedical Engineering at the University of Toronto. He is a co-founder of Interface Biologics Inc (formed in 2001 with medical technologies being sold and developed in Canada, Europe and the US) and currently the director for Physical Science Faculty in Techna at the University Hospital Network/University of Toronto.  He has been appointed an International Fellow of Biomaterials Science and Engineering (FBSE) (2004), a Fellow of the American Institute for Medical and Biological Engineering (2009) , a Fellow of the American Association for the Advancement of Science (2011), and a Fellow of the Canadian Academy of Health Sciences (2013).  He has received several awards for his innovation and industry related activity including the Julia Levy Award from the Canadian Society for Chemical Industry for translation of knowledge to product, the Natural Sciences and Engineering Research Council of Canada’s Synergy Award in 2012, and the 2014 Manning prize (Canada’s top Entrepreneurship/Innovator award) .

For event information, please contact Terry Milson,, 905-525-9140, ext. 27391.